title: Does amiodarone reduce sudden death and cardiac mortality after myocardial infarction? The European Myocardial Infarct Amiodarone Trial (EMIAT).
authors.affiliation: Department of Medicine, University of Pavia, Italy.
authors.forename: P J
authors.initials: PJ
authors.lastname: Schwartz
authors.forename: A J
authors.initials: AJ
authors.lastname: Camm
authors.forename: G
authors.initials: G
authors.lastname: Frangin
authors.forename: M J
authors.initials: MJ
authors.lastname: Janse
authors.forename: D G
authors.initials: DG
authors.lastname: Julian
authors.forename: P
authors.initials: P
authors.lastname: Simon
mesh_terms: D000328:Adult; D000368:Aged; D000638:Amiodarone / Q000627:therapeutic use*; D016757:Death, Sudden, Cardiac / Q000517:prevention & control*; D005060:Europe; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000188:drug therapy* / Q000401:mortality*; D012107:Research Design
chemical_list: D000638:Amiodarone